[144] Essent Group Ltd. SEC Filing

Rhea-AI Filing Summary

Essent Group Ltd. (symbol ESNT) filed a Form 144 reporting a proposed sale of 11,479 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $746,135.00. The shares represent restricted stock that vested on March 1, 2023 and were received as compensation; the filer acquired and paid for the shares on that same date. The filing lists approximately 98,533,757 shares outstanding and indicates an approximate sale date of September 18, 2025. No securities were sold by the filer in the prior three months according to the form.

Positive

• Compliance: The filing specifies broker, class, number of shares, market value, acquisition date, and nature of acquisition, meeting Rule 144 disclosure elements
• Source of shares: Shares were acquired via restricted stock vesting and paid as compensation, which is clearly stated

Negative

• Limited execution detail: No trading plan date or specific execution instructions (e.g., 10b5-1 plan) are provided to clarify how the sale will be carried out
• No intent timeline: The form gives an approximate sale date but lacks a schedule or size-by-date breakdown, limiting transparency on sell timing

Insights

Securities Compliance Analyst

TL;DR: Insider plans a routine sale of vested restricted shares through a broker; filing conforms to Rule 144 disclosure requirements.

The Form 144 shows a straightforward proposed disposition of vested restricted stock received as compensation. The use of a recognized broker (Fidelity Brokerage Services LLC) and specification of an approximate sale date support standard compliance with Rule 144 timing and notice expectations. The filing states no sales in the past three months, which is relevant to calculating short-swing and Rule 144 aggregation considerations. The disclosure that acquisition and payment occurred on the vesting date is explicit and avoids ambiguity about consideration.

Equity Trading Specialist

TL;DR: The position is modest relative to total shares outstanding; market impact likely limited given size.

The filer intends to sell 11,479 shares valued at $746,135 against an outstanding share base of 98,533,757. This represents a small fraction of outstanding stock, suggesting limited immediate market impact from the proposed sale. The filing does not disclose a multi-date sell program or 10b5-1 plan date, which would inform execution pacing; it only lists an approximate sale date of September 18, 2025. Execution through Fidelity provides standard market access but no further trading parameters are provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	11479	746135.00	98533757	09/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2023	Restricted Stock Vesting	Issuer			11479	03/01/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Essent Group's Form 144 (ESNT) report?

It reports a proposed sale of 11,479 common shares through Fidelity with an aggregate market value of $746,135.00 and an approximate sale date of September 18, 2025.

How were the shares acquired according to the filing?

The filing states the shares were acquired on March 1, 2023 as restricted stock vesting and paid as compensation.

Does the filing report recent sales by the insider?

The form indicates "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Through which broker will the sale occur?

The broker listed is Fidelity Brokerage Services LLC, located in Smithfield, RI, and the securities exchange is the NYSE.

How significant is the planned sale relative to outstanding shares?

The filing lists 98,533,757 shares outstanding; the proposed 11,479 shares are a very small fraction of that total.